Amgen (AMGN) Tops Q4 EPS by 14c; Guides FY19 Below the Street

Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.42, $0.14 better than the analyst estimate of $3.28. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $5.87 billion.

GUIDANCE:

Amgen sees FY2019 EPS of $13.10-$14.30, versus the consensus of $14.62. Amgen sees FY2019 revenue of $218-22.9 billion, versus the consensus of $22.94 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• NVE Corporation names new CEO and expands board to seven members
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge